Compare CHE & AFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHE | AFRM |
|---|---|---|
| Founded | 1970 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 24.9B |
| IPO Year | 1994 | 2020 |
| Metric | CHE | AFRM |
|---|---|---|
| Price | $550.39 | $65.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 36 |
| Target Price | ★ $617.00 | $96.22 |
| AVG Volume (30 Days) | 133.1K | ★ 3.8M |
| Earning Date | 10-27-2026 | 11-05-2026 |
| Dividend Yield | ★ 0.51% | N/A |
| EPS Growth | N/A | ★ 3586.67 |
| EPS | ★ 15.43 | 0.47 |
| Revenue | $2,529,978,000.00 | ★ $4,261,082,000.00 |
| Revenue This Year | $7.99 | $31.15 |
| Revenue Next Year | $6.43 | $24.40 |
| P/E Ratio | ★ $35.54 | $139.70 |
| Revenue Growth | 4.06 | ★ 32.15 |
| 52 Week Low | $365.21 | $42.10 |
| 52 Week High | $562.24 | $90.44 |
| Indicator | CHE | AFRM |
|---|---|---|
| Relative Strength Index (RSI) | 61.23 | 38.87 |
| Support Level | $495.36 | $60.68 |
| Resistance Level | $555.98 | $70.02 |
| Average True Range (ATR) | 16.14 | 3.80 |
| MACD | 1.70 | -0.78 |
| Stochastic Oscillator | 82.12 | 7.03 |
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Founded in 2012, Affirm is a market leader in the buy now, pay later space with around $36 billion in transaction volume in fiscal 2025. Affirm offers both zero-interest financing, which is merchant-subsidized, and interest-bearing loans, which function as personal loans that are approved on a per-transaction basis. Over 70% of Affirm's transaction volume comes from its interest-bearing loans, which also constitute the majority of its revenue. Affirm primarily operates in the United States, which accounted for more than 95% of its revenue in 2025, but it has also expanded to Canada and the United Kingdom.